Bulky Disease
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Obinutuzumab and Lenalidomide in Treating Patients With Previously Untreated Stage II-IV Grade 1-3a Follicular Lymphoma (NCT02871219) | M.D. Anderson Cancer Center | 2016-12-06 |
Track Bulky Disease automatically
Every clearance here is in the API, with alerts when new ones post.